Strongbridge Biopharma plc - FORM 10-K - EX-21.1 - February 28, 2020

Attached files

file filename
10-K - 10-K - Strongbridge Biopharma plcsbbp-20191231x10k.htm
EX-32.1 - EX-32.1 - Strongbridge Biopharma plcsbbp-20191231ex3219a542d.htm
EX-31.1 - EX-31.1 - Strongbridge Biopharma plcsbbp-20191231ex31160edd2.htm
EX-23.1 - EX-23.1 - Strongbridge Biopharma plcsbbp-20191231ex231062bbe.htm
EX-10.26 - EX-10.26 - Strongbridge Biopharma plcsbbp-20191231ex10264568a.htm
EX-10.25 - EX-10.25 - Strongbridge Biopharma plcsbbp-20191231ex10255df5a.htm
EX-10.16 - EX-10.16 - Strongbridge Biopharma plcsbbp-20191231ex101628adb.htm
EX-10.8 - EX-10.8 - Strongbridge Biopharma plcsbbp-20191231ex10841ffff.htm
EX-4.1 - EX-4.1 - Strongbridge Biopharma plcsbbp-20191231ex4119e9447.htm

Exhibit 21.1

 

Subsidiaries of the Company 

 

Strongbridge U.S. Inc. (a Delaware corporation)

Strongbridge Dublin Limited (a private limited company incorporated under the laws of Ireland)

Cortendo AB (publ) (a public limited liability company incorporated under the laws of Sweden)

 

Strongbridge Biopharma plc Reports